| CLIN |
PATH |
DEFINITIONS |
| |
|
PRIMARY
TUMOR (T) |
|
|
|
TX |
Primary tumor cannot be
assessed |
|
|
|
TX |
Primary tumor cannot be
assessed |
|
|
|
T0 |
No evidence of primary
tumor |
|
|
|
Ta |
Papillary noninvasive
carcinoma |
|
|
|
Tis |
Carcinoma in situ |
|
|
|
T1 |
Tumor invades subepithelial
connective tissue |
|
|
|
T2 |
Tumor invades muscularis |
|
|
|
T3 |
Tumor invades beyond
muscularis into peripelvic fat or renal parenchyma (For
renal pelvis only) |
|
|
|
T3 |
Tumor invades beyond
muscularis into periureteric fat (For ureter only) |
|
|
|
T4 |
Tumor invades adjacent
organs or through the kidney into parinephric fat |
|
|
|
LYMPH
NODE (N) |
|
|
|
NX |
Regional lymph nodes cannot
be assessed |
|
|
|
N0 |
No regional lymph node
metastasis |
|
|
|
N1 |
Metastasis in a single
lymph node, 2 cm or less in greatest dimension |
|
|
|
N2 |
Merastasis in a single
lymph node, more than 2 cm but not more than 5 cm in
greatest dimension, or multiple lymph nodes, none more
than 5 cm in greatest dimension |
|
|
|
N3 |
Metastasis in a lymph node
more than 5 cm in greatest dimension |
| |
|
DISTANT
METASTASIS (M) |
|
|
|
MX |
Presence of disatant
metastasis cannot be assessed |
|
|
|
M1 |
No disatant metastasis |
|
|
|
M1 |
Disatant metastasis |